In
this work, an electrochemiluminescence (ECL) immunosensor utilizing
MnCO3 nanospheres as a novel ECL luminophor and the HWRGWVC
(HC-7) heptapeptide as an efficient antibody capturer for site-directed
immobilization with high affinity was proposed. MnCO3 nanospheres
prepared by a homogeneous precipitation method exhibited high ECL
efficiency, low toxicity, favorable biocompatibility, and excellent
stability. After the functionalization of polydimethyldiallylammonium
chloride (PDDA), the obtained MnCO3/PDDA could combine
with gold nanoparticles (Au NPs) via electrostatic interaction (MnCO3/PDDA/Au). Besides, HC-7 as a small peptide ligand has demonstrated
an ability to bind the Fc portion of an antibody with high affinity.
Because the end of HC-7 is a cysteine, it can connect to MnCO3/PDDA/Au via a Au–S bond. Then, the antibody could
be effectively captured by HC-7 through specific interaction with
a better maintained activity than traditional coupling reaction. To
verify the practicability of the constructed immunosensor, β-amyloid1–42 oligomers (Aβ) were employed as an analyte.
On the basis of the above points, the immunosensor performed favorable
ECL property to Aβ concentrations in a wide linear range (0.1
pg/mL to 10 ng/mL) with a low detection limit (19.95 fg/mL). With
excellent repeatability, selectivity, and stability, this method opened
up a new avenue for realizing the ultrasensitive detection of Aβ
and other biomarkers in a real sample analysis.